Bhanko Pharma Private Limited

Bhanko Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24290TG2020PTC147370 Incorporated 30 December 2020 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2022
₹6.07 Lakh
Latest filing
Net profit · FY 2022
₹20,758
Net margin 3.4%
EBITDA · FY 2022
₹55,301
EBITDA margin 9.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Bhanko Pharma Private Limited

Data last updated:

Bhanko Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 30 December 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC147370. Its GSTIN is 36AAJCB5414D1ZZ (Telangana).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anuradha Perni and Bhargava Naidu Perni.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.366 Door No. 20 – M/366 Bhargava Nilayam Mathrusri Nagar Society Miyapur, Hyderabad, Telangana, India – 500049.

As per the financials filed for FY 2022, the company reported a revenue of ₹6.07 Lakh. For the same year it recorded a net profit of ₹20,758 (net margin 3.4%) and EBITDA of ₹55,301 (EBITDA margin 9.1%).

Bhanko Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0008722).

Company details

CIN U24290TG2020PTC147370
Registration Number 147370
Incorporation Date 30 December 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0008722

Recognitions & Rankings of Bhanko Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-TS-09-0008722

Contact details

Bhanko Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No.366 Door No. 20 – M/366 Bhargava Nilayam Mathrusri Nagar Society Miyapur, Hyderabad, Telangana, India – 500049
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Bhanko Pharma Private Limited, buy the company report.

Comprehensive company report
Bhanko Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Bhanko Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

Financials of Bhanko Pharma Private Limited

FY 2025 filings available

Bhanko Pharma Private Limited reported revenue of ₹6.07 Lakh for FY 2022.

Revenue · FY 2022
₹6.07 Lakh
Net profit · FY 2022
₹20,758 margin 3.4%
EBITDA · FY 2022
₹55,301 margin 9.1%

Financial Statement Summary

MetricsFY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹6.07 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹55,301
Profit Before Tax
Tax Expense
Net Profit (PAT)₹20,758
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21
Profitability
EBITDA Margin9.1%
Net Profit Margin3.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bhanko Pharma Private Limited, buy the company report.

Board of directors of Bhanko Pharma Private Limited

Bhanko Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Gowri Sankara Rao PerniAdditional Director09 Sep 20215 Years 1 MonthsCurrent
Anuradha PerniDirector30 Dec 20205 Years 9 MonthsCurrent
Bhargava Naidu PerniDirector30 Dec 20205 Years 9 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bhanko Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Bhanko Pharma Private Limited has 1 active EPFO establishment as of Apr 05, 2024.

Active EPFO establishments
1

GST

Bhanko Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAJCB5414D1ZZTelanganaActive06 Feb 2021

To see the full GST registrations and return filing status of Bhanko Pharma Private Limited, buy the company report.

Recent activity

Bhanko Pharma Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Gowri Sankara Rao Perni was appointed as Additional Director on 09 Sep 2021.

AGM
Bhanko Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bhanko Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Gowri Sankara Rao Perni was appointed as Additional Director.
Ceased
Perni Komali ceased to be Director.
Appointed
Anuradha Perni was appointed as Director.
Appointed
Bhargava Naidu Perni was appointed as Director.
Incorporation
30 Dec 2020
Bhanko Pharma Private Limited was registered on 30 Dec 2020 with Roc Hyderabad & aged 5 years 9 months as per MCA records.

Frequently asked questions

Bhanko Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 30 December 2020 (6+ years old) and is registered under CIN U24290TG2020PTC147370.

Bhanko Pharma has 3 current directors:

The latest financial statements of Bhanko Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Bhanko Pharma is 36AAJCB5414D1ZZ, registered in Telangana.

The CIN (Corporate Identification Number) of Bhanko Pharma is U24290TG2020PTC147370. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bhanko Pharma was incorporated on 30 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.

Gowri Sankara Rao Perni was appointed as Additional Director on 09 Sep 2021. Perni Komali ceased to be Director on 09 Sep 2021. Anuradha Perni was appointed as Director on 30 Dec 2020. Bhanko Pharma has 4 board changes on record in total.

Yes, Bhanko Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0008722).

The registered office of Bhanko Pharma is at Plot No.366 Door No. 20 – M366 Bhargava Nilayam Mathrusri Nagar Society Miyapur, Hyderabad, Telangana, India – 500049.

Bhanko Pharma operates in the pharma industry, in the api manufacturers segment.